We studied anti-VEGF #outcomes in ~100,000 cases across 3 common #retina disorde…
[ad_1]
We studied anti-VEGF #outcomes in ~100,000 cases across 3 common #retina disorders. #Vision improves more in RVO-related #macula edema vs #AMD & #DME, but shows a larger gap vs corresponding randomized trials. We need durable more effective #treatments!
https://t.co/cTwLDeVCZc
[ad_2]
Source by Thomas Ciulla, MD, MBA